Apheresis Market Size, Share, Trends, and Forecast Report 2025-2033 from stanley huds's blog

IMARC Group’s report titled “Apheresis Market Report by Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or Leukopheresis), Lymphocytes (Lymphopheresis or Lymphapheresis), RBC's (Erythropheresis)), Product (Devices, Disposables and Reagents, Software), Technology (Centrifugation, Membrane Separation, Selective Adsorption), Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Others), End User (Blood Centers, Hospitals, and Others), and Region 2025-2033”. The global apheresis market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.26% during 2025-2033.

Factors Affecting the Growth of the Apheresis Industry:

• Increasing Prevalence of Chronic Diseases:

The treatment of chronic diseases including cancer and autoimmune and blood-connected conditions requires therapeutic blood procedures that extract harmful elements. Through apheresis techniques healthcare professionals achieve selective component retrieval which controls disease manifestations in these conditions. Apheresis procedures serve diagnostic purposes through medical applications in different chronic diseases. The analysis of blood components or identification of illness biomarkers becomes possible through apheresis procedures which assist in diagnosing and monitoring disease conditions.

• Technological Advancements:

The advancement of apheresis technology systems allows scientists to create better blood component separation methods. Advanced technology implements higher productivity and shorter operations along with greater collection output which drives enhanced apheresis procedure performances. Apheresis machines of today benefit from advanced automated features which enable controlled blood component management. Measurement accuracy enables medical professionals to correctly separate and collect individual blood elements which decreases procedural mistakes while producing better treatment results.

• Growing Demand for Blood Components:

Apheresis technology enables nurses to collect particular blood elements including platelets along with plasma and white blood cells (WBCs). Blood component therapies serve different medical purposes in transfusion medicine as well as in the fields of hematology and oncology and immunology. Hemostasis functions heavily depend on platelets because medical patients with bleeding problems or surgical needs or chemotherapy treatment require these products often. Through apheresis single donors can contribute platelets that meet the elevated needs of the medical sector.

Grab a sample PDF of this report: https://www.imarcgroup.com/apheresis-market/requestsample

Leading Companies Operating in the Global Apheresis Industry:

• Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
• B. Braun SE
• Charles River Laboratories International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Haemonetics Corporation
• Haier Biomedical
• Kaneka Corporation
• Medica S.p.a.
• Miltenyi Biotec
• Nikkiso Co. Ltd.
• Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
• Terumo Bct Inc. (Terumo Corporation).

Apheresis Market Report Segmentation:

By Component:

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or Leukopheresis)
• Lymphocytes (Lymphopheresis or Lymphapheresis)
• RBC's (Erythropheresis)

Plasma (Plasmapheresis) represents the largest segment due to the increasing demand for plasma-derived medications and therapeutic applications in treating a wide range of medical conditions.

By Product:

• Devices
• Disposables and Reagents
• Software

Disposables and reagents account for the majority of the market share owing to their essential role in apheresis procedures, requiring frequent replenishment.

By Technology:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Centrifugation exhibits a clear dominance in the market driven by its widespread adoption, efficiency in separating blood components, and versatility in accommodating various apheresis procedures.

By Procedure:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Donor/automated apheresis holds the biggest market share on account of its efficiency, convenience, and ability to collect specific blood components from donors for therapeutic and transfusion purposes.

By Application:

• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

Hematological disorders hold the biggest market share as apheresis procedures play a critical role in the management and treatment of various hematologic disorders, including leukemia, lymphoma, and aplastic anemia.

By End User:

• Blood Centers
• Hospitals
• Others

Blood centers represent the largest segment. They serve as key facilities for blood collection, processing, and distribution, playing a central role in meeting the demand for blood components derived from apheresis procedures.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the apheresis market, which can be attributed to its well-established healthcare infrastructure, high prevalence of chronic diseases, strong regulatory framework, and extensive adoption of advanced medical technologies.

Global Apheresis Market Trends:

There is a growing emphasis on personalized or precision medicine approaches, which require tailoring blood component treatments collected through apheresis procedures to meet individual patient needs. Apheresis procedures are finding expanded therapeutic applications beyond traditional uses, including treatment of neurological disorders, organ transplantation, and immune-mediated diseases, thereby diversifying the market. Growing awareness among healthcare professionals and patients about the benefits of apheresis procedures is leading to greater acceptance and use of these technologies, contributing to market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

 IMARC Group
 134 N 4th St. Brooklyn, NY 11249, USA
 Email: [email protected]
 Tel No:(D) +91 120 433 0800
 United States: +1-631-791-1145